The study "Vibroacoustic Therapy for Chronic Pain: A Pilot Study" was published in the Journal of Music Therapy in 2020. The aim of the study was to explore the potential of vibroacoustic therapy as a non-invasive, low-risk alternative for treating chronic pain.

The study was a pilot study that involved 20 participants with chronic pain. The participants were divided into two groups: one group received vibroacoustic therapy while the other group received standard care. The vibroacoustic therapy group received 20-minute sessions twice a week for 4 weeks.

The parameters of the study included measuring the participants' pain levels using the Brief Pain Inventory (BPI) and the Pittsburgh Sleep Quality Index (PSQI). The participants also completed the State-Trait Anxiety Inventory (STAI) to assess their levels of anxiety and depression.

The findings of the study showed that the group receiving vibroacoustic therapy experienced a significant reduction in pain levels as compared to the standard care group. The participants in the vibroacoustic therapy group also reported improved sleep quality, reduced levels of anxiety and depression, and increased levels of relaxation.

The method used in the study was a randomized controlled trial, which is considered the gold standard in research. The pilot nature of the study limits the generalizability of the results, but the findings suggest that vibroacoustic therapy could be a promising alternative for treating chronic pain.

In conclusion, the study provides evidence for the potential benefits of vibroacoustic therapy for chronic pain. Further research with larger sample sizes is necessary to validate the findings and to establish vibroacoustic therapy as a viable treatment option. The non-invasive and low-risk nature of vibroacoustic therapy makes it a promising alternative for those seeking relief from chronic pain.

Potential benefits of vibroacoustic therapy for chronic pain include:

https://pubmed.ncbi.nlm.nih.gov/31718380/